Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3740899013 | Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3740900015 | Isoniazid and pyrazinamide and rifampicin only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3740901016 | Isoniazid and pyrazinamide and rifampin only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has active ingredient | Rifampicin | true | Inferred relationship | Some | 2 | |
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Is a | Isoniazid and pyrazinamide and rifampicin only product | true | Inferred relationship | Some | ||
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has active ingredient | Pyrazinamide | true | Inferred relationship | Some | 1 | |
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has active ingredient | Isoniazid | true | Inferred relationship | Some | 3 | |
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Is a | Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | true | Inferred relationship | Some | ||
Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Isoniazid 50 mg and pyrazinamide 300 mg and rifampicin 120 mg oral tablet | Is a | True | Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets